Lawsuit Claims Takeda, Eli Lilly Hid Bladder Cancer Risks Associated with Diabetes Drug Actos
May 8, 2018 Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company are facing a proposed class action in which the plaintiff alleges the companies attempted to cover up that their type II diabetes treatment, Actos, presented a risk of bladder cancer.